UniProt ID | DAXX_MOUSE | |
---|---|---|
UniProt AC | O35613 | |
Protein Name | Death domain-associated protein 6 | |
Gene Name | Daxx | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 739 | |
Subcellular Localization | Cytoplasm . Nucleus, nucleoplasm . Nucleus, PML body . Nucleus, nucleolus . Chromosome, centromere . Dispersed throughout the nucleoplasm, in PML/POD/ND10 nuclear bodies, and in nucleoli. Colocalizes with histone H3.3, ATRX, HIRA and ASF1A at PML-nuc | |
Protein Description | Transcription corepressor known to repress transcriptional potential of several sumoylated transcription factors. Down-regulates basal and activated transcription. Its transcription repressor activity is modulated by recruiting it to subnuclear compartments like the nucleolus or PML/POD/ND10 nuclear bodies through interactions with MCSR1 and PML, respectively. Seems to regulate transcription in PML/POD/ND10 nuclear bodies together with PML and may influence TNFRSF6-dependent apoptosis thereby. Inhibits transcriptional activation of PAX3 and ETS1 through direct protein-protein interactions. Modulates PAX5 activity; the function seems to involve CREBBP. Acts as an adapter protein in a MDM2-DAXX-USP7 complex by regulating the RING-finger E3 ligase MDM2 ubiquitination activity. Under non-stress condition, in association with the deubiquitinating USP7, prevents MDM2 self-ubiquitination and enhances the intrinsic E3 ligase activity of MDM2 towards TP53, thereby promoting TP53 ubiquitination and subsequent proteasomal degradation. Upon DNA damage, its association with MDM2 and USP7 is disrupted, resulting in increased MDM2 autoubiquitination and consequently, MDM2 degradation, which leads to TP53 stabilization. Acts as histone chaperone that facilitates deposition of histone H3.3. Acts as targeting component of the chromatin remodeling complex ATRX:DAXX which has ATP-dependent DNA translocase activity and catalyzes the replication-independent deposition of histone H3.3 in pericentric DNA repeats outside S-phase and telomeres, and the in vitro remodeling of H3.3-containing nucleosomes. Does not affect the ATPase activity of ATRX but alleviates its transcription repression activity. Upon neuronal activation associates with regulatory elements of selected immediate early genes where it promotes deposition of histone H3.3 which may be linked to transcriptional induction of these genes. Required for the recruitment of histone H3.3:H4 dimers to PML-nuclear bodies (PML-NBs); the process is independent of ATRX and facilitated by ASF1A; PML-NBs are suggested to function as regulatory sites for the incorporation of newly synthesized histone H3.3 into chromatin. Proposed to mediate activation of the JNK pathway and apoptosis via MAP3K5 in response to signaling from TNFRSF6 and TGFBR2. Interaction with HSPB1/HSP27 may prevent interaction with TNFRSF6 and MAP3K5 and block DAXX-mediated apoptosis. In contrast, in lymphoid cells JNC activation and TNFRSF6-mediated apoptosis may not involve DAXX. Plays a role as a positive regulator of the heat shock transcription factor HSF1 activity during the stress protein response (By similarity).. | |
Protein Sequence | MATDDSIIVLDDDDEDEAAAQPGPSNLPPNPASTGPGPGLSQQATGLSEPRVDGGSSNSGSRKCYKLDNEKLFEEFLELCKTETSDHPEVVPFLHKLQQRAQSVFLASAEFCNILSRVLARSRKRPAKIYVYINELCTVLKAHSIKKKLNLAPAASTTSEASGPNPPTEPPSDLTNTENTASEASRTRGSRRQIQRLEQLLALYVAEIRRLQEKELDLSELDDPDSSYLQEARLKRKLIRLFGRLCELKDCSSLTGRVIEQRIPYRGTRYPEVNRRIERLINKPGLDTFPDYGDVLRAVEKAATRHSLGLPRQQLQLLAQDAFRDVGVRLQERRHLDLIYNFGCHLTDDYRPGVDPALSDPTLARRLRENRTLAMNRLDEVISKYAMMQDKTEEGERQKRRARLLGTAPQPSDPPQASSESGEGPSGMASQECPTTSKAETDDDDDDDDDDDEDNEESEEEEEEEEEEKEATEDEDEDLEQLQEDQGGDEEEEGGDNEGNESPTSPSDFFHRRNSEPAEGLRTPEGQQKRGLTETPASPPGASLDPPSTDAESSGEQLLEPLLGDESPVSQLAELEMEALPEERDISSPRKKSEDSLPTILENGAAVVTSTSVNGRVSSHTWRDASPPSKRFRKEKKQLGSGLLGNSYIKEPMAQQDSGQNTSVQPMPSPPLASVASVADSSTRVDSPSHELVTSSLCSPSPSLLLQTPQAQSLRQCIYKTSVATQCDPEEIIVLSDSD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
25 | Phosphorylation | AAAQPGPSNLPPNPA HHHCCCCCCCCCCCC | 57.84 | - | |
219 | Phosphorylation | QEKELDLSELDDPDS HHHCCCHHHCCCCCC | 35.46 | 27566939 | |
249 | Ubiquitination | FGRLCELKDCSSLTG HHHHHHCCCHHHHCC | 34.10 | - | |
372 | Phosphorylation | RRLRENRTLAMNRLD HHHHHCHHHHHHHHH | 30.37 | 25177544 | |
418 | Phosphorylation | PSDPPQASSESGEGP CCCCCCCCCCCCCCC | 29.41 | - | |
430 | Phosphorylation | EGPSGMASQECPTTS CCCCCCCCCCCCCCC | 20.02 | - | |
441 | Phosphorylation | PTTSKAETDDDDDDD CCCCCCCCCCCCCCC | 49.98 | 29514104 | |
458 | Phosphorylation | DDEDNEESEEEEEEE CCCCCHHHHHHHHHH | 44.09 | 25195567 | |
472 | Phosphorylation | EEEEKEATEDEDEDL HHHHHHHHCCCCHHH | 45.09 | 12529400 | |
502 | Phosphorylation | GDNEGNESPTSPSDF CCCCCCCCCCCHHHH | 37.16 | 12529400 | |
504 | Phosphorylation | NEGNESPTSPSDFFH CCCCCCCCCHHHHCH | 63.65 | 25293948 | |
505 | Phosphorylation | EGNESPTSPSDFFHR CCCCCCCCHHHHCHH | 26.28 | 25293948 | |
507 | Phosphorylation | NESPTSPSDFFHRRN CCCCCCHHHHCHHCC | 46.98 | 25293948 | |
515 | Phosphorylation | DFFHRRNSEPAEGLR HHCHHCCCCCCCCCC | 43.05 | 26824392 | |
516 | Phosphorylation | FFHRRNSEPAEGLRT HCHHCCCCCCCCCCC | 52.67 | 24719451 | |
523 | Phosphorylation | EPAEGLRTPEGQQKR CCCCCCCCCCHHHCC | 30.63 | 26824392 | |
533 | Phosphorylation | GQQKRGLTETPASPP HHHCCCCCCCCCCCC | 40.41 | 23649490 | |
535 | Phosphorylation | QKRGLTETPASPPGA HCCCCCCCCCCCCCC | 20.94 | 19854140 | |
538 | Phosphorylation | GLTETPASPPGASLD CCCCCCCCCCCCCCC | 32.60 | 27180971 | |
543 | Phosphorylation | PASPPGASLDPPSTD CCCCCCCCCCCCCCC | 38.94 | 23649490 | |
567 | Phosphorylation | EPLLGDESPVSQLAE HHHHCCCCHHHHHHH | 35.03 | 23649490 | |
570 | Phosphorylation | LGDESPVSQLAELEM HCCCCHHHHHHHHHH | 23.90 | 23649490 | |
593 | Phosphorylation | ISSPRKKSEDSLPTI CCCCCCCCCCCCCCH | 50.07 | 26160508 | |
596 | Phosphorylation | PRKKSEDSLPTILEN CCCCCCCCCCCHHHC | 32.00 | 26160508 | |
599 | Phosphorylation | KSEDSLPTILENGAA CCCCCCCCHHHCCCE | 43.41 | 26160508 | |
609 | Phosphorylation | ENGAAVVTSTSVNGR HCCCEEEEECCCCCE | 21.49 | 30635358 | |
610 | Phosphorylation | NGAAVVTSTSVNGRV CCCEEEEECCCCCEE | 13.69 | 30635358 | |
611 | Phosphorylation | GAAVVTSTSVNGRVS CCEEEEECCCCCEEC | 27.59 | 30635358 | |
612 | Phosphorylation | AAVVTSTSVNGRVSS CEEEEECCCCCEECC | 17.22 | 30635358 | |
618 | Phosphorylation | TSVNGRVSSHTWRDA CCCCCEECCCCCCCC | 18.29 | 30635358 | |
619 | Phosphorylation | SVNGRVSSHTWRDAS CCCCEECCCCCCCCC | 23.29 | 26643407 | |
621 | Phosphorylation | NGRVSSHTWRDASPP CCEECCCCCCCCCCC | 24.92 | 26643407 | |
626 | Phosphorylation | SHTWRDASPPSKRFR CCCCCCCCCCCHHHH | 41.45 | 25266776 | |
627 | Phosphorylation | HTWRDASPPSKRFRK CCCCCCCCCCHHHHH | 38.61 | 24719451 | |
629 | Phosphorylation | WRDASPPSKRFRKEK CCCCCCCCHHHHHHH | 39.59 | 26745281 | |
658 | Phosphorylation | EPMAQQDSGQNTSVQ CCCCCCCCCCCCCCC | 37.63 | 25777480 | |
662 | Phosphorylation | QQDSGQNTSVQPMPS CCCCCCCCCCCCCCC | 23.53 | 25777480 | |
663 | Phosphorylation | QDSGQNTSVQPMPSP CCCCCCCCCCCCCCC | 26.72 | 29472430 | |
669 | Phosphorylation | TSVQPMPSPPLASVA CCCCCCCCCCCCHHH | 32.66 | 27087446 | |
674 | Phosphorylation | MPSPPLASVASVADS CCCCCCCHHHHHCCC | 26.37 | 29472430 | |
677 | Phosphorylation | PPLASVASVADSSTR CCCCHHHHHCCCCCC | 18.71 | 25293948 | |
681 | Phosphorylation | SVASVADSSTRVDSP HHHHHCCCCCCCCCC | 24.70 | 25777480 | |
682 | Phosphorylation | VASVADSSTRVDSPS HHHHCCCCCCCCCCC | 22.30 | 25777480 | |
683 | Phosphorylation | ASVADSSTRVDSPSH HHHCCCCCCCCCCCC | 38.37 | 25777480 | |
687 | Phosphorylation | DSSTRVDSPSHELVT CCCCCCCCCCCHHHH | 25.99 | 22942356 | |
689 | Phosphorylation | STRVDSPSHELVTSS CCCCCCCCCHHHHHH | 33.28 | 22942356 | |
694 | Phosphorylation | SPSHELVTSSLCSPS CCCCHHHHHHHCCCC | 25.81 | 25159016 | |
695 | Phosphorylation | PSHELVTSSLCSPSP CCCHHHHHHHCCCCH | 17.52 | 25159016 | |
696 | Phosphorylation | SHELVTSSLCSPSPS CCHHHHHHHCCCCHH | 24.83 | 25159016 | |
699 | Phosphorylation | LVTSSLCSPSPSLLL HHHHHHCCCCHHHHH | 33.43 | 25159016 | |
701 | Phosphorylation | TSSLCSPSPSLLLQT HHHHCCCCHHHHHCC | 15.72 | 25159016 | |
703 | Phosphorylation | SLCSPSPSLLLQTPQ HHCCCCHHHHHCCCC | 35.67 | 25293948 | |
736 | Phosphorylation | PEEIIVLSDSD---- HHHEEEEECCC---- | 24.95 | 21082442 | |
738 | Phosphorylation | EIIVLSDSD------ HEEEEECCC------ | 41.67 | 21082442 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DAXX_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RASF1_MOUSE | Rassf1 | physical | 18566590 | |
MDM2_MOUSE | Mdm2 | physical | 18566590 | |
P53_MOUSE | Trp53 | physical | 18566590 | |
CR3L1_MOUSE | Creb3l1 | physical | 20211142 | |
DMAP1_MOUSE | Dmap1 | physical | 20211142 | |
DMAP1_MOUSE | Dmap1 | physical | 14978102 | |
SUMO1_MOUSE | Sumo1 | physical | 21383010 | |
SUMO2_MOUSE | Sumo2 | physical | 21383010 | |
KINH_MOUSE | Kif5b | physical | 18932217 | |
P53_MOUSE | Trp53 | physical | 15364927 | |
MDM2_MOUSE | Mdm2 | physical | 15364927 | |
STK4_MOUSE | Stk4 | physical | 21572393 | |
TGFR2_HUMAN | TGFBR2 | physical | 11483955 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"The phagosomal proteome in interferon-gamma-activated macrophages."; Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,Thibault P.; Immunity 30:143-154(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-515, AND MASSSPECTROMETRY. | |
"Large-scale phosphorylation analysis of mouse liver."; Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-736, AND MASSSPECTROMETRY. | |
"Homeodomain-interacting protein kinase 1 modulates Daxx localization,phosphorylation, and transcriptional activity."; Ecsedy J.A., Michaelson J.S., Leder P.; Mol. Cell. Biol. 23:950-960(2003). Cited for: INTERACTION WITH HIPK1, MUTAGENESIS OF SER-502 AND SER-669,PHOSPHORYLATION AT SER-219; THR-472; SER-502; SER-515; THR-523;SER-626 AND SER-669, AND MASS SPECTROMETRY. |